首页 正文

Multi-pathway targeted therapy of MASH-HCC using miR-22

{{output}}
Background: The treatment options for hepatocellular carcinoma (HCC) are limited, and there is no effective drug that can improve long-term survival rates. Complicated cocktails consisting of multiple medications with toxicities ... ...